P10 price target lowered to $15 from $16 at Stephens

Stephens lowered the firm’s price target on P10 to $15 from $16 and keeps an Overweight rating on the shares. In early 2022, the company announced its goal of $5B in capital raised / deployed in two years, the firm tells investors. Now, with a full quarter remaining, the company is more than $1B above its target, which is impressive, especially considering the market pressure that have grown since the onset of the goal, the firm says.